Background: Surgical treatment of complex giant pituitary adenomas (GPAs) presents significant challenges. The efficacy and safety of combining transsphenoidal and transcranial approaches for these tumors remain controversial. In this largest cohort of patients with complex GPAs, we compared the surgical outcomes between those undergoing a combined regimen and a non-combined regimen. We also examined the differences in risks of complications, costs, and logistics between the two groups, which might offer valuable information for the appropriate management of these patients. Patients and Methods: This was a multicenter retrospective cohort study conducted at 13 neurosurgical centers. Consecutive patients who received a combined or non-combined regimen for complex GPAs were enrolled. The primary outcome was gross total resection, while secondary outcomes included complications, surgical duration, and relapse. A propensity score-based weighting method was used to account for differences between the groups. Results: Out of 647 patients [298 (46.1%) women, mean age: 48.5 ± 14.0 years] with complex GPAs, 91 were in the combined group and 556 were in the noncombined group. Compared with the noncombined regimen, the combined regimen was associated with a higher probability of gross total resection [50.5% vs. 40.6%, odds ratio (OR): 2.18, 95% confidence interval (CI): 1.30–3.63, P = 0.003]. The proportion of patients with life-threatening complications was lower in the combined group than in the non-combined group (4.4% vs. 11.2%, OR: 0.25, 95% CI: 0.08–0.78, P = 0.017). No marked differences were found between the groups in terms of other surgical or endocrine-related complications. However, the combined regimen exhibited a longer average surgery duration of 1.3 h (P < 0.001) and higher surgical costs of 22,000 CNY (~ 3,000 USD, P = 0.022) compared with the noncombined approach. Conclusions: The combined regimen offered increased rates of total resection and decreased incidence of life-threatening complications, which might be recommended as the first-line choice for these patients.
Objective: It is imperative to prevent cerebrospinal fluid (CSF) leakage following an endoscopic endonasal approach (EEA). This study aims to evaluate the efficacy of a simple, triple-layer reconstruction strategy for preventing CSF rhinorrhea following the standard EEA for pituitary adenomas. Methods: We retrospectively analyzed 213 patients who underwent a standard EEA for primary pituitary adenomas between January 2023 and March 2025. All patients received a simple reconstruction consisting of artificial dura mater placement, gelatin sponge packing, and porcine fibrin sealant sealing, without autograft harvesting. Intraoperative CSF leakage was graded according to the Kelly classification. Postoperative outcomes including CSF rhinorrhea, meningitis, and subjective olfactory changes were recorded during at least three months of follow-up. The study focused exclusively on reconstruction-related outcomes and did not assess other endpoints such as gross total resection, endocrine remission, visual recovery, and diabetes insipidus. This retrospective, single-arm case series reports preliminary outcomes of a triple-layer reconstruction strategy. Results: Intraoperative CSF leakage occurred in 97 patients (45.54%): Grade 1 in 41, Grade 2 in 45, and Grade 3 in 11. Postoperative CSF rhinorrhea developed in 3 of 213 patients (1.41%; 95% CI: 0.29%–4.25%). Among the 97 patients with intraoperative CSF leakage, the postoperative leak rate was 3.1% (3/97; 95% CI: 0.67%–9.08%). Among the 11 patients with Grade 3 intraoperative leaks, no postoperative CSF rhinorrhea was observed in this series. Meningitis occurred in 4 patients (1.88%), two of whom also had CSF rhinorrhea. Postoperative hyposmia was reported by 2 patients (0.94%), both of whom recovered normal olfaction by 6 months. Conclusions: In this retrospective case series, the triple-layer reconstruction strategy was associated with a low postoperative CSF leak rate following standard EEA for primary pituitary adenomas. Among the small number of patients with Grade 3 intraoperative leaks in this series, no postoperative CSF rhinorrhea was observed. The technique also avoided autograft harvest and donor-site morbidity. These findings should be considered preliminary and require confirmation in prospective, controlled studies.